articleNatureFeb 1, 2022HYBRID OA

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

University of Cambridge · University of Miyazaki · +36 more institutions

PubMed
Indexed incrossrefdatacitepubmed

Abstract

Abstract The SARS-CoV-2 Omicron BA.1 variant emerged in 2021 1 and has multiple mutations in its spike protein 2 . Here we show that the spike protein of Omicron has a higher affinity for ACE2 compared with Delta, and a marked change in its antigenicity increases Omicron’s evasion of therapeutic monoclonal and vaccine-elicited polyclonal neutralizing antibodies after two doses. mRNA vaccination as a third vaccine dose rescues and broadens neutralization. Importantly, the antiviral drugs remdesivir and molnupiravir retain efficacy against Omicron BA.1. Replication was similar for Omicron and Delta virus isolates in human nasal epithelial cultures. However, in lung cells and gut cells, Omicron demonstrated lower…

Citation impact

1,162
total citations
FWCI
113.91
Percentile
100%
References
58
Citations per year

Authors

222

Topics & keywords

Keywords
  • Virology
  • Infectivity
  • Virus
  • Viral entry
  • Biology
  • Chemistry
  • Viral replication
  • Molecular biology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding